NOVAREX Co.,Ltd. (KOSDAQ:194700)
South Korea · Delayed Price · Currency is KRW 14,520
+20 (0.14%)
At close: Jun 10, 2026
NOVAREX Market Cap
NOVAREX has a market cap or net worth of 249.43 billion as of June 10, 2026. Its market cap has increased by 18.41% in one year.
Market Cap
249.43B
Enterprise Value
237.18B
Revenue
404.26B
Ranking
n/a
PE Ratio
7.25
Stock Price
14,520.00
Market Cap Chart
Since November 14, 2018, NOVAREX's market cap has increased from 180.98B to 249.43B, an increase of 37.83%. That is a compound annual growth rate of 4.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 249.43B | 0.65% |
| Dec 30, 2025 | 247.83B | 86.67% |
| Dec 30, 2024 | 132.77B | -38.22% |
| Dec 28, 2023 | 214.90B | 19.61% |
| Dec 29, 2022 | 179.68B | -41.23% |
| Dec 30, 2021 | 305.72B | -1.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samyang Biopharm | 383.69B |
| ImmuneOncia Therapeutics | 380.15B |
| HEM Pharma | 308.58B |
| CellBion | 231.39B |
| Vivozon Pharmaceutical | 201.25B |
| DAE HWA Pharmaceutical | 189.18B |
| High Tech Pharm | 151.84B |
| GC WellBeing | 143.83B |